Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Rivastigmine 9.5mg/24hours transdermal patches |
| BNF code | 0411000E0AAAGAG |
| Virtual Therapeutic Moiety | Rivastigmine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | patch |
| Unit dose unit of measure | patch |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Rivastigmine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 9.500 |
| Strength value numerator unit | mg |
| Strength value denominator | 24.000 |
| Strength value denominator unit | hour |
| Ontology Drug Form & Route | |
| Form & Route | patch.transdermal |
| Dose Form | |
| Formulation | Transdermal patch |
| Drug Route | |
| Route | Transdermal |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Almuriva 9.5mg/24hours transdermal patches (Sandoz Ltd) | |
| Alzest 9.5mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) | |
| Exelon 9.5mg/24hours transdermal patches (Abacus Medicine Ltd) | |
| Exelon 9.5mg/24hours transdermal patches (CST Pharma Ltd) | |
| Exelon 9.5mg/24hours transdermal patches (Lexon (UK) Ltd) | |
| Exelon 9.5mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) | |
| Prometax 9.5mg/24hours transdermal patches (Sandoz Ltd) | |
| Zeyzelf 9.5mg/24hours twice weekly transdermal patches (Luye Pharma Ltd) | |
| Virtual Medicinal Product Packs | |
| Rivastigmine 9.5mg/24hours transdermal patches 30 patch | |
| Rivastigmine 9.5mg/24hours transdermal patches 8 patch | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.